PYC pyc therapeutics limited

cd40 ligand program, page-4

  1. 11,715 Posts.
    lightbulb Created with Sketch. 1543
    It must be getting close now Peace. Found this link interesting. Don't think Prof Andreas was listed at the time of collaboration. Did I miss this at the time?

    http://www.pepscan.com/therapeutics/company/scientific-advisory-board/

    Prof. Andreas Plückthun studied chemistry at the University of Heidelberg and obtained a PhD from the University of California San Diego. He worked as a postdoctoral fellow in the Chemistry Department of Harvard University. From 1985 until 1993, he was group leader at the Genzentrum and Max-Planck-Institut für Biochemie in Martinsried, Germany. He was appointed as a Professor of Biochemistry in Zürich in 1993. His pioneering scientific work on antibody engineering, protein engineering and directed evolution has made him one of the most highly cited scientists in protein science and his work has been honored by a number of international awards and membership of the German Academy of Science. In 1992, he co-founded the biotechnology company MorphoSys, a leading antibody company with successful deals with all major pharmaceutical companies. In 2004 he co-founded the biotech company Molecular Partners, which is located in Zurich.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.36
Change
0.005(0.37%)
Mkt cap ! $793.2M
Open High Low Value Volume
$1.40 $1.40 $1.36 $211.9K 152.9K

Buyers (Bids)

No. Vol. Price($)
1 4103 $1.36
 

Sellers (Offers)

Price($) Vol. No.
$1.39 2028 1
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.